Cephalalgia

1. VAN WELIE RF, van Welie FC, Dahan A, Tavakoli M, et al
   Corneal confocal microscopy reveals nerve fiber alterations in migraine irrespective of subtype or visual hypersensitivity.
   Cephalalgia. 2026;46:3331024251414172.
   

   >> Share

   
   
2. LI X, Li R, Liu G, Qiu D, et al
   Iron deposition network mapping of disease occurrence and clinical manifestations in migraine: A prospective study.
   Cephalalgia. 2026;46:3331024261416488.
   

   >> Share

   
   
3. PHILLIPS K, Gokhale K, Damase-Michel C, Dolk H, et al
   Migraine, associated treatments and risk of miscarriage: A matched cohort study and nested case-control study using the CPRD pregnancy register.
   Cephalalgia. 2026;46:3331024251414634.
   

   >> Share

   
   
4. BRENNA E, Ferro M, Sumelahti ML, Cajuso T, et al
   Clinical and genetic characterization of non-optimal triptan response among migraine patients.
   Cephalalgia. 2026;46:3331024251414621.
   

   >> Share

   
   
5. DAGHLAS I, Chasman DI
   Mendelian randomization applied to migraine research: Opportunities and challenges.
   Cephalalgia. 2026;46:3331024251414834.
   

   >> Share

   
   

   
   Headache

6. NWAOBI SE
   Useful considerations for treating migraine in patients with autism.
   Headache. 2026 Jan 29. doi: 10.1111/head.70054.
   

   >> Share

   
   
7. CHEN H, Li Y
   Safety analysis of gepants for migraine treatment: A pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database.
   Headache. 2026 Jan 28. doi: 10.1111/head.70049.
   

   >> Share

   
   
8. ZELDICH D, Calderon N, Goor-Aryeh I, Lichtenstein GR, et al
   Case report: Treatment of temporomandibular joint disorder pain with V3 nerve block procedure.
   Headache. 2026;66:332-335.
   

   >> Share

   
   
9. SHIN L, Mentz O, Gelfand AA, de Prado BM, et al
   Gepants for headache prevention in children and adolescents: A multicenter chart review study.
   Headache. 2026;66:239-248.
   

   >> Share

   
   
10. PATEL EJ, Sharon JD, Levin M, Luebke AE, et al
    Calcitonin gene-related peptide in the audiovestibular system.
    Headache. 2026;66:278-285.
    

    >> Share

    
    

    
    Neurology

11. CARONNA E, Mas-de-Les-Valls R, Egeo G, Millan Vazquez M, et al
    Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.
    Neurology. 2026;106:e214659.
    

    >> Share

    
    

    
    Rev Neurol

12. VALLADALES-RESTREPO LF, Diaz-Arteaga C, Navarrete-Santa LF, Santander-Pai MJ, et al
    Migraine and the Excessive Dispensation of Triptans: A Real-World Evidence Study of Colombian Patients.
    Rev Neurol. 2026;81:46355.
    

    >> Share

    
    

    
    Rev Neurol (Paris)

13. LUCAS C, Revol A, Faist F, Defawe C, et al
    EPIGAME a vignette-based study of management practices of medication overuse in migraine, among French neurologists.
    Rev Neurol (Paris). 2026 Jan 27:S0035-3787(26)00020.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share